Duncan, Gary E., Seiya Miyamoto, and Jeffrey A. Lieberman.
"Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation." Journal of Pharmacology and Experimental Therapeutics
(2003):
.
Web. 19 April. 2024.